133 Publications (Page 5 of 6)
2006
Hope Is the Thing With FeathersCripe, Larry DJAMA, vol. 296, (no. 15), pp. 1815-1816, Oct 18, 2006.
| Journal Article
In Chronic Lymphocytic Leukemia, Zap70 Identifies a Survival Pathway Signal Cascade Involving p85 PI-3-Kinase, CrkL, and Cbl with Syk En Route to JNK1 and bcl-2Hartman, Amy D⋅Wilson-Weekes, Annique⋅Cripe, Larry D⋅Bennett, Brydon⋅Friedman, Glenn⋅Worland, Peter⋅Druker, Brian⋅Ren, Shuyue⋅Skorski, Tomasz and Boswell, H. ScottBlood, vol. 108, (no. 11), pp. 584, 2006-11-16.
| Journal Article
Loss of Heterozygosity in Bone Marrows of Patients with Iron-Deficiency AnemiaCzader, Magdalena⋅Czader, Magdalena⋅Czader, Magdalena⋅Wang, Mingsheng⋅Wang, Mingsheng⋅Wang, Mingsheng⋅Cripe, Larry D⋅Cripe, Larry D⋅Cripe, Larry D⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Orazi, Attilio⋅Orazi, Attilio and Orazi, AttilioBlood, vol. 108, (no. 11), pp. 4863, 2006-11-16.
| Journal Article
Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemiaFrankel, Arthur⋅Frankel, Arthur E⋅Surendranathan, Asha⋅Surendranathan, Asha⋅Black, Jennifer H⋅Black, Jennifer H⋅White, Angela⋅White, Angela⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Cripe, Larry D and Cripe, Larry DCancer, vol. 106, (no. 10), pp. 2164, 15 May 2006.
| Journal Article
Phase I/II Pharmacodynamic Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Acute Myeloid Leukemia (AML)Lancet, Jeffrey⋅Baer, Maria R⋅Cripe, Larry D⋅List, Alan F⋅Marcelletti, John F⋅Multani, Pratik S and Sikic, Branimir IBlood, vol. 108, (no. 11), pp. 422, 2006-11-16.
| Journal Article
Phase I/II, Randomized, MultiCenter, Dose-Ascension Study of the p38MAPK Inhibitor Scio-469 in Patients with Myelodysplastic Syndrome (MDS)Sokol, Lubomir⋅Cripe, Larry⋅Kantarjian, Hagop⋅Sekeres, Mikkael A⋅Parmar, Simrit⋅Greenberg, Peter⋅Goldberg, Stuart⋅Bhushan, Vikas⋅Shammo, Jamile⋅Hohl, Raymond⋅Li, Yu-Ping⋅Lowe, Ann⋅Zhu, Joy and List, AlanBlood, vol. 108, (no. 11), pp. 2657, 2006-11-16.
| Journal Article
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997Cripe, Larry D⋅Rader, Kevin⋅Tallman, Martin S⋅Gordon, Michael S⋅Paietta, Elisabeth M⋅Bennett, John M⋅Neuberg, Donna S⋅Litzow, Mark R⋅O'Brien, Timothy E and Rowe, Jacob MLeukemia Research, vol. 30, (no. 7), pp. 823-827, 2006.
| Journal Article
2005
12- O-Tetradecanoylphorbol-13-acetate in acute myeloid leukemiaChan, Rebecca J and Cripe, Larry DLeukemia Research, vol. 29, (no. 10), pp. 1108, 2005.
| Journal Article
A Music Imagery Intervention for Adults with Acute Leukemia in Protective EnvironmentsBurns, Debra S⋅Burns, Debra S⋅Azzouz, Faouzi⋅Azzouz, Faouzi⋅Hincher, Katie⋅Hincher, Katie⋅Rutledge, Cheryl⋅Rutledge, Cheryl⋅Monahan, Patrick⋅Monahan, Patrick⋅Cripe, Larry D and Cripe, Larry DBlood, vol. 106, (no. 11), pp. 3130, 2005-11-16.
| Journal Article
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group StudyGanjoo, Kristen⋅Ganjoo, Kristen N⋅Robertson, Michael J⋅Robertson, Michael J⋅Fisher, William⋅Fisher, William⋅Jung, Sin Ho⋅Jung, Sin-Ho⋅McClean, John⋅McClean, John⋅Huh, Sang Yoon⋅Huh, Sang Y⋅Bufill, Jose⋅Bufill, Jose⋅Williams, Sheron⋅Williams, Sheron⋅Cripe, Larry D and Cripe, Larry DAmerican journal of clinical oncology, vol. 28, (no. 2), pp. 172, 2005-Apr.
| Journal Article
A Randomized, Open-Label Study of Lestaurtinib (CEP-701), an Oral FLT3 Inhibitor, Administered in Sequence with Chemotherapy in Patients with Relapsed AML Harboring FLT3 Activating Mutations: Clinical Response Correlates with Successful FLT3 InhibitionLevis, Mark⋅Smith, B. Douglas⋅Beran, Miloslav⋅Baer, Maria R⋅Erba, Harry P⋅Cripe, Larry⋅Coutre, Steven⋅Advani, Anjali⋅Perl, Alexander⋅Devetten, Marcel⋅Stuart, Robert⋅Tallman, Martin S⋅Brown, Peter⋅Tremmel, Lothar and Small, DonaldBlood, vol. 106, (no. 11), pp. 403, 2005-11-16.
| Journal Article
In AML, Cbl Serves as Nexus for Signaling from Flt3, and Is Required for Coupling JNK1 in a Pathway of Survival and Proliferation Involving c-jun/AP-1Hartman, Amy D⋅Hartman, Amy D⋅Wilson-Weekes, Annique⋅Wilson-Weekes, Annique⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Burgess, Gem S⋅Burgess, Gem S⋅Hincher, Kathryn J⋅Hincher, Kathryn J⋅Cripe, Larry D⋅Cripe, Larry D⋅Boswell, H. Scott and Boswell, H. ScottBlood, vol. 106, (no. 11), pp. 1203, 2005-11-16.
| Journal Article
Oncologist Assisted Spiritual Intervention Study (OASIS): patient acceptability and initial evidence of effects.Kristeller, Jean L⋅Rhodes, Mark⋅MARK, R. H⋅Cripe, Larry D⋅CRIPE, LARRY D⋅Sheets, Virgil and VIRGIL, S. HInternational journal of psychiatry in medicine, vol. 35, (no. 4), pp. 329-347, 2005.
| Journal Article
Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group ExperienceRowe, Jacob M⋅Li, Xiaochun⋅Cassileth, Peter A⋅Appelbaum, Frederick R⋅Schiffer, Charles A⋅Wiernik, Peter H⋅Litzow, Mark R⋅Cripe, Larry D⋅Lazarus, Hillard M⋅Paietta, Elisabeth⋅Dewald, Gordon W⋅Weinstein, Howard J⋅Ogden, Angela K⋅Woods, William G⋅Shepherd, Lois⋅Feusner, James H⋅Bloomfield, Clara D and Tallman, Martin SBlood, vol. 106, (no. 11), pp. 546, 2005-11-16.
| Journal Article
2004
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study,Vaena, Daniel A⋅Walker, P.⋅Pennington, K.⋅Stephens, A.⋅Stender, MJ⋅Yiannoutsos, Constantin T⋅Young, C.⋅Stoner, C. and Cripe, Larry DLeukemia Research, vol. 28, (no. 1), pp. 49-52, 2004.
| Journal Article
2003
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trialsPaietta, Elisabeth M⋅Neuberg, Donna S⋅Bennett, John M⋅Dewald, Gordon W⋅Rowe, Jacob M⋅Cassileth, Peter A⋅Cripe, Larry D⋅Tallman, Martin S and Wiernik, Peter HLeukemia, vol. 17, (no. 8), pp. 1544-1550, 2003.
| Journal Article
Teaching Patients How to Improve Communication with their Health Care Providers: A Unique Workshop ExperienceFisch, Michael⋅Fisch, Michael⋅Zichi Cohen, Marlene⋅Cohen, Marlene Z⋅Rutledge, Cheryl⋅Rutledge, Cheryl⋅Cripe, Larry D and Cripe, Larry DJournal of cancer education : the official journal of the American Association for Cancer Education, vol. 18, (no. 4), pp. 193, 2003-Winter.
| Journal Article
2002
Thrombopoietin Administered During Induction Chemotherapy to Patients With Acute Myeloid Leukemia Induces Transient Morphologic Changes That May Resemble Chronic Myeloproliferative DisordersDouglas, VK⋅Tallman, Martin S⋅Cripe, Larry D and Peterson, Lo Ann CAmerican Journal of Clinical Pathology, vol. 117, (no. 6), pp. 844-850, 2002.
| Journal Article
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.Witzig, Thomas E⋅Flinn, Ian W⋅Gordon, Leo I⋅Emmanouilides, Christos⋅Czuczman, Myron S⋅Saleh, Mansoor N⋅Cripe, Larry⋅Wiseman, Gregory⋅Olejnik, Teresa⋅Multani, Pratik S and White, Christine AJournal of Clinical Oncology, vol. 20, (no. 15), pp. 3262-9, 2002/Aug/1.
| Journal Article
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.Gordon, Leo I⋅Witzig, Thomas E⋅Wiseman, Greg A⋅Flinn, Ian W⋅Spies, Stewart S⋅Silverman, Daniel H⋅Emmanuolides, Christos⋅Cripe, Larry⋅Saleh, Mansoor⋅Czuczman, Myron S⋅Olejnik, Teresa⋅White, Christine A and Grillo-López, Antonio JSeminars in oncology, vol. 29, (no. 1S2), pp. 87-92, February 2002.
| Journal Article
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.Gordon, Leo I⋅Witzig, Thomas E⋅Wiseman, Greg A⋅Flinn, Ian W⋅Spies, Stewart S⋅Silverman, Daniel H⋅Emmanouilides, Christos⋅Cripe, Larry⋅Saleh, Mansoor⋅Czuczman, Myron S⋅Olejnik, Teresa⋅White, Christine A⋅Grillo-López, Antonio J and Emmanuolides, ChristosSeminars in oncology, vol. 29, (no. 1 Suppl 2), pp. 87-92, 2002/Feb.
| Journal Article
2000
Acute myeloid leukemia in adults.Cripe, Larry D and Hinton, SCurrent Treatment Options in Oncology, vol. 1, (no. 1), pp. 9-17, 2000/Apr.
| Journal Article
Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and ManagementPorcu, P⋅Porcu, Pierluigi⋅Cripe, Larry D⋅Cripe, L D⋅Ng, E W⋅Ng, Elizabeth W⋅Bhatia, S⋅Bhatia, Sumeet⋅Danielson, Constance M⋅Danielson, C M⋅Orazi, Attilio⋅Orazi, Attilio⋅McCarthy, Leo J and McCarthy, L JLeukemia & Lymphoma, vol. 39, (no. 1-2), pp. 18, 20000000.
| Journal Article
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995Gordon, Michael S⋅Gordon, Michael S⋅Young, M L⋅Young, Molly L⋅Tallman, Martin S⋅Tallman, Martin S⋅Cripe, Larry D⋅Cripe, L D⋅Bennett, John M⋅Bennett, John M⋅Paietta, Elisabeth⋅Paietta, Elisabeth M⋅Longo, W⋅Longo, Walter⋅Gerad, Henry⋅Gerad, H⋅Mazza, J⋅Mazza, Joseph⋅Rowe, Jacob M and Rowe, J MLeukemia Research, vol. 24, (no. 10), pp. 875, 2000.
| Journal Article
1999
A hot-start reverse transcription-polymerase chain reaction protocol that initiates multiple analyses simultaneously.Tanzer, L R⋅Hu, Y⋅Cripe, L and Moore, R EAnalytical biochemistry, vol. 273, (no. 2), pp. 307-310, September 10, 1999.
| Journal Article